Cadian Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-245,000
Closed -$34.4M 41
2017
Q3
$34.4M Buy
245,000
+70,000
+40% +$9.82M 1.61% 19
2017
Q2
$21.3M Buy
+175,000
New +$21.3M 1.04% 28